SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000885590-16-000082
Filing Date
2016-01-04
Accepted
2016-01-04 17:53:29
Documents
1
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3169
  Complete submission text file 0000885590-16-000082.txt   4749
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL A8 H7L 4A8
Business Address
MELAS KYRIAZI THEO (Reporting) CIK: 0001216078 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 161319488